While some workaday compounding pharmacies have strong track records, research suggests that errors remain more common at compounding pharmacies than at large drug manufacturers
Most available studies are small, uncontrolled, or industry-sponsored
The peptide is often sold through unregulated channels as a 'research chemical' or unauthorised medicine, raising significant concerns about purity, dosage accuracy, and contamination
Tambar emphasizes the importance of personalized treatment plans and regular follow-ups to monitor for potential side effects like nausea, headaches, and fluid retention
Due to the compounds plasma half-life of approximately 3.86.9 hours [5] , twice-daily (BID) dosing may provide more sustained NNMT inhibition
Its also normal to cycle BPC-157 peptide therapy by taking one month off for every three months of use